Inconsistent with the present study, the serum MEG3 expression was significantly down-expressed in BC patients; as a result, it was revealed that the expressions of miR-182 and miRNA 29 were significantly elevated and had a positive correlation with the degree of malignancy. This evidence concerns the gene MEG3 and breast cancer.